Literature DB >> 32649074

Remdesivir for the Treatment of Covid-19 - Preliminary Report.

Samantha Gillenwater1, Franck Rahaghi1, Anas Hadeh1.   

Abstract

Entities:  

Year:  2020        PMID： 32649074     DOI： 10.1056/NEJMc2022236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.

Authors:  Jordana Muñoz-Basagoiti; Daniel Perez-Zsolt; Jorge Carrillo; Julià Blanco; Bonaventura Clotet; Nuria Izquierdo-Useros
Journal:  Membranes (Basel)       Date:  2021-01-18

2.  Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa.

Authors:  Youngji Jo; Lise Jamieson; Ijeoma Edoka; Lawrence Long; Sheetal Silal; Juliet R C Pulliam; Harry Moultrie; Ian Sanne; Gesine Meyer-Rath; Brooke E Nichols
Journal:  Open Forum Infect Dis       Date:  2021-01-29       Impact factor: 3.835

3.  Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial.

Authors:  Gilmar Reis; Eduardo Augusto Dos Santos Moreira Silva; Daniela Carla Medeiros Silva; Lehana Thabane; Gurmit Singh; Jay J H Park; Jamie I Forrest; Ofir Harari; Castilho Vitor Quirino Dos Santos; Ana Paula Figueiredo Guimarães de Almeida; Adhemar Dias de Figueiredo Neto; Leonardo Cançado Monteiro Savassi; Aline Cruz Milagres; Mauro Martins Teixeira; Maria Izabel Campos Simplicio; Luciene Barra Ribeiro; Rosemary Oliveira; Edward J Mills
Journal:  JAMA Netw Open       Date:  2021-04-01

Review 4.  The "Invisible Enemy" SARS-CoV-2: Viral Spread and Drug Treatment.

Authors:  Alina Tanase; Aniko Manea; Alexandra Denisa Scurtu; Lavinia Melania Bratu; Doina Chioran; Alina Dolghi; Iren Alexoi; Hazzaa AAbed; Voichita Lazureanu; Cristina Adriana Dehelean
Journal:  Medicina (Kaunas)       Date:  2022-02-10       Impact factor: 2.430

5.  Efficacy of early use of remdesivir: a systematic review of subgroup analysis.

Authors:  M D Gil-Sierra; M P Briceño-Casado; E J Alegre-Del Rey; M Sánchez-Hidalgo
Journal:  Rev Esp Quimioter       Date:  2022-03-17       Impact factor: 2.515

Review 6.  Cyclodextrins in the antiviral therapy.

Authors:  László Jicsinszky; Katia Martina; Giancarlo Cravotto
Journal:  J Drug Deliv Sci Technol       Date:  2021-05-20       Impact factor: 3.981
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.